Analyst Price Target is $31.33
▲ +91.64% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for LENZ Therapeutics in the last 3 months. The average price target is $31.33, with a high forecast of $34.00 and a low forecast of $28.00. The average price target represents a 91.64% upside from the last price of $16.35.
Current Consensus is
Buy
The current consensus among 5 contributing investment analysts is to buy stock in LENZ Therapeutics. This Buy consensus rating has held steady for over two years.